Valid Consent for Genomic Epidemiology in Developing Countries
| dc.contributor.author | Chokshi, D.A. | |
| dc.contributor.author | Thera, M.A. | |
| dc.contributor.author | Parker, M. | |
| dc.contributor.author | Diakite, M. | |
| dc.contributor.author | Makani, J. | |
| dc.contributor.author | Kwiatkowski, D.P. | |
| dc.contributor.author | Doumbo, O.K. | |
| dc.date.accessioned | 2013-04-04T12:51:29Z | |
| dc.date.available | 2013-04-04T12:51:29Z | |
| dc.date.issued | 2007 | |
| dc.description.abstract | Genomic research has the potential to improve global health by elucidating basic mechanisms of disease, susceptibility, and resistance, thereby guiding the development of preventive interventions [1]. Recently developed methods for exploring how human genetic variation affects resistance are likely to provide strategic clues about vaccine development for researchers working on malaria, HIV, tuberculosis, and other diseases of the developing world | en_GB |
| dc.identifier.citation | Chokshi, D. A., Thera, M. A., Parker, M., Diakite, M., Makani, J., Kwiatkowski, D. P., & Doumbo, O. K. (2007). Valid consent for genomic epidemiology in developing countries. PLoS medicine, 4(4), e95. | |
| dc.identifier.other | doi:10.1371/journal.pmed.0040095 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/783 | |
| dc.language.iso | en | en_GB |
| dc.publisher | PLoS Medicine | |
| dc.relation.ispartofseries | PLoS Medicine 4(4): e95. | |
| dc.subject | Valid Consent | en_GB |
| dc.subject | Genomic Epidemiology | en_GB |
| dc.subject | Developing Countries | en_GB |
| dc.title | Valid Consent for Genomic Epidemiology in Developing Countries | en_GB |
| dc.type | Article | en_GB |
